How does Maxim do with it's ratings????? I chec
Post# of 640
Posted On: 04/21/2015 8:11:17 PM
How does Maxim do with it's ratings?????
I checked as many as I could find. Maxim has several recent ratings, too soon to rate performance. Unfortunately I could only find 5 older samples. There were more, but no date on the article.
Only the first one is less than 1 year and I have the open on the date of the buy rating. All the others have the price of the recommendation and the share price one year later. I call this in the "Fallacy of Small Sampling", but it is the best I got at this time.
ISR---7/16/14 $2.33---to $1.52 - loss 35% or .65
CREE--5/28/12 $26.44--to $60.66 - up 2.29 fold
LYV---5/11/12 $9.02---to $14.00 up 1.55 fold
PSTI--7/25/12 $3.50---to $3.06 loss 13% or .87
TKMR--6/18/13 $4,80---to $13.61 up 2.83 fold
Average stock one year later, 163% up. from here, RIBT $4.23 open on April 9th to $6.89 or near maxim's target of $7.00
Q1 should be great compared to last year, a very easy Q to beat. The key is, will it beat Q4. The big problem is the Brazil currency was 21% higher on average than last year Q1. Q4 was 12% higher. The affect on RIBT is less because of exports from Brazil, but the proportion will be 21% over 12% compared to Q4. The key will be new sales from protein, cosmetics and craft beer ingredients. Q2 could be tough as well, but once we round the horn on the high Brazil currency and if it goes back to more normal, the negatives could turn completely around and be positives. The last 1/2 of the year could be super, 1st half tough.
I found no evidence that Maximum does fund raises with the "Buy Rating" companies soon after. I am not saying they won't have one.
I checked as many as I could find. Maxim has several recent ratings, too soon to rate performance. Unfortunately I could only find 5 older samples. There were more, but no date on the article.
Only the first one is less than 1 year and I have the open on the date of the buy rating. All the others have the price of the recommendation and the share price one year later. I call this in the "Fallacy of Small Sampling", but it is the best I got at this time.
ISR---7/16/14 $2.33---to $1.52 - loss 35% or .65
CREE--5/28/12 $26.44--to $60.66 - up 2.29 fold
LYV---5/11/12 $9.02---to $14.00 up 1.55 fold
PSTI--7/25/12 $3.50---to $3.06 loss 13% or .87
TKMR--6/18/13 $4,80---to $13.61 up 2.83 fold
Average stock one year later, 163% up. from here, RIBT $4.23 open on April 9th to $6.89 or near maxim's target of $7.00
Q1 should be great compared to last year, a very easy Q to beat. The key is, will it beat Q4. The big problem is the Brazil currency was 21% higher on average than last year Q1. Q4 was 12% higher. The affect on RIBT is less because of exports from Brazil, but the proportion will be 21% over 12% compared to Q4. The key will be new sales from protein, cosmetics and craft beer ingredients. Q2 could be tough as well, but once we round the horn on the high Brazil currency and if it goes back to more normal, the negatives could turn completely around and be positives. The last 1/2 of the year could be super, 1st half tough.
I found no evidence that Maximum does fund raises with the "Buy Rating" companies soon after. I am not saying they won't have one.
(0)
(0)